Table 1:

Patient and Tumor Characteristics

	Total patients (n=228)	Metastasis (n=9)	Death (n=4)
Age of Diagnosis (months)
Mean	29	28	30
Range	1–127	19–40	20–40
Gender: number (% of total)
Male	104 (46%)	4 (1.7%)	1 (0.4%)
Female, number (% of total)	124 (54%)	5 (2.1%)	3 (1.3%)
Laterality: number (% of total)
Right	117 (51%)	5 (2.1%)	2 (0.8%)
Left	111 (49%)	4 (1.7%)	2 (0.8%)
Follow-Up Time (months)
Mean	60	35	25
Range	5–135	5–95	5–57
Eye Classification at Diagnosis
Children’s Oncology Group: Number (% with classification)
D	7 (3%)	1 (0.4%)	0
E	29 (13%)	5 (2.1%)	2 (0.8%)
Murphree: Number (% with classification)
D	26 (11%)	0	0
E	61 (27%)	0	0
Philadelphia: Number (% with classification)
C	1 (0.4%)	0	0
D	1 (0.4%)	0	0
E	66 (29%)	2 (0.8%)	2 (0.8%)
Reese-Ellsworth: Number (% with classification)
V	113 (49%)	9 (3.9%)	4 (1.7%)
Pathology: Number (% with pathology)
Anterior segment invasion	9 (4%)	1 (0.4%)	1 (0.4%)
Ciliary body invasion	0	0	0
Massive Choroidal Invasion	31 (14%)	4 (1.7%)	3 (1.3%)
Invasion into nerve, prelaminar	69 (30%)	1 (0.4%)	0
Invasion into nerve, postlaminar	43 (19%)	4 (1.7%)	2 (0.8%)
Invasion into nerve, at cut section	0	0	0
Negative, none of the above	95 (42%)	1 (0.4%)	0
Unavailable	1 (0.4%)	0	0